|
Digital
Library of the European Council for Modelling and Simulation |
Title: |
Individual-Level
Simulation Model For Cost Benefit Analysis In Healthcare |
Authors: |
Nagesh
Shukla, Vu Lam Cao, Van Hoang Phuong, Marian
Shanahan, Allison Ritter, Pascal Perez |
Published in: |
(2016).ECMS 2016 Proceedings edited
by: Thorsen Claus, Frank Herrmann, Michael Manitz, Oliver Rose, European Council for Modeling and
Simulation. doi:10.7148/2016 ISBN:
978-0-9932440-2-5 30th
European Conference on Modelling and Simulation, Regensburg Germany, May 31st
– June 3rd, 2016 |
Citation
format: |
Nagesh
Shukla, Vu Lam Cao, Van Hoang Phuong, Marian
Shanahan, Allison Ritter, Pascal Perez (2016). Individual-Level Simulation
Model For Cost Benefit Analysis In Healthcare, ECMS 2016 Proceedings edited
by: Thorsten Claus, Frank Herrmann, Michael Manitz,
Oliver Rose European Council for Modeling and
Simulation. doi:10.7148/2016-0138 |
DOI: |
http://dx.doi.org/10.7148/2016-0138 |
Abstract: |
Illicit drug use creates significant
burden at societal, family and personal levels. Every year substantial
resources are allocated for treatment and the consequences of illicit drug
use in Australia and around the world. Heroin is one of the major forms of
illicit drugs. Several independent heroin treatment strategies or
interventions exist and state-of-the art research demonstrates their efficacy
and relative cost-effectiveness. However, assessing total potential gains and
burden from providing all treatment interventions or varying the mix of
heroin treatments has never been attempted. This paper proposed an
individual-level simulation model (ISM)which
addresses net social benefit over a lifetime that can accommodate the
complexity of individuals going in and out of multiple treatments and their
corresponding costs and benefits arising from different treatments during the
life-course of heroin users in the context of New South Wales (NSW)Australia.
This model is intended to serve as an effective tool for economic evaluation
and policy making in the illicit drug area in Australia. The validity of the
model has been assessed by comparing short term outcomes or examining the
status of participants at a various points of time predicted from the model
with other data sets that were not used to parameterise
the model. Initial model results have been also presented to highlight
different types of scenario analysis that can be conducted in future. |
Full
text: |